Brolucizumab 12- and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials. - Singer, Michael; Khanani, Arshad M.; Wolf, Armin; Flores, Rita; Chhablani, Jay; B, Guruprasad; Clemens, Andreas; Gedif, Kinfemichael; Liu, Xiaoxi; Mulyukov, Zufar; Querques, Giuseppe (Ophthalmologica, 2022)